EPO and Alzheimer disease: In transgenic mice modeling Alzheimer’s disease, intermittent hypoxia activated cerebrocortical erythropoietin and brain-derived neurotrophic factor expression [17], and attenuated Aβ plaque formation and the expression of pro-inflammatory interleukins 1 and 6 [18].